Friends, in this video, I will be revealing why I'm buying this buy & hold stock forever.
2 extracted signals · 2 resolved · 0 still active
The Patient InvestorIndependent analyst profile- Source published
- 30 Nov 2025, 19:14 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
AI-generated source summary
The analysis focuses on two stocks: Brookfield Asset Management (BAM) and Mama's Creations. For BAM, the current price is $52.74, and the analyst believes that BAM is a good investment, he gives a target of 70$. The fail price has been calculated as 45$. He notes that BAM is currently down 3% year-to-date, and there's a divergence between BAM and its parent company, Brookfield Corporation (BN). The analyst expects BAM to catch up in performance and mentions BAM's strong fundamentals, including assets under management over a trillion dollars. The analysis states that Mama's Creations (MAMA), currently priced at $11.32, has a target of 15$, and the fail price has been calculated as 9$. It highlights the CEO's focus on improving margins, and projects 20-24% annualized returns over the next five years due to both organic growth and acquisitions.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
The Patient Investor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.